MYC: From Biology to Therapy
January 7-10; La Jolla, California
Co-chairpersons: Dean W. Felsher, MD, PhD, Martin Eilers, PhD, Carla Grandori, DPhil, PhD, and James E. Bradner, MD

Translation of the Cancer Genome
Computational and Systems Biology of Cancer
February 7-11; San Francisco, California
Co-chairpersons: William C. Hahn, MD, PhD, Lynda Chin, MD, William R. Sellers, MD, Andrea Califano, PhD, Peter K. Jackson, PhD, and Brenda J. Andrews, PhD

AACR-SNMMI Joint Conference
February 11-14; San Diego, California
Co-chairpersons: Carolyn J. Anderson, PhD, David R. Piwnica-Worms, MD, PhD, and Christopher H. Contag, PhD

Tumor Angiogenesis and Vascular Normalization: Bench to Bedside to Biomarkers
March 5-8; Orlando, Florida
Co-chairpersons: Rakesh K. Jain, PhD, Harold F. Dvorak, MD, Napoleone Ferrara, MD, FAACR, Peter Carmeliet, MD, PhD, and Helen X. Chen, MD

Workshop: Accelerating Anticancer Agent Development and Validation
May 6-8; Bethesda, Maryland
Chairperson: H. Kim Lyerly, MD

Advances in Brain Cancer Research
May 27-30; Washington, D.C.
Co-chairpersons: Eric C. Holland, MD, Franziska Michor, PhD, Martine F. Roussel, PhD, and Michael D. Taylor, MD, PhD

Metabolism and Cancer
June 7-10; Bellevue, Washington
Co-chairpersons: Ralph J. DeBerardinis, MD, PhD, David M. Sabatini, MD, PhD, Almut Schulze, PhD

Workshop: Methods in Cancer Biostatistics — Clinical Trial Designs for Targeted Agents
June 7-13; Lake Tahoe, California
Chairperson: Steven Piantadosi, MD, PhD

Precision Medicine Series: Integrating Clinical Genomics and Cancer Therapy
June 13-16; Salt Lake City, Utah
Co-chairpersons: Charles L. Sawyers, MD, FAACR, Elaine R. Mardis, PhD, and Arul M. Chinnaiyan, MD, PhD

13th International Conference on Malignant Lymphoma
June 17-20; Lugano, Switzerland
Co-chairpersons: Franco Cavalli, MD, and Michele Ghielmini, MD, PhD

AACR-SIC-EACR Joint Conference: Anticancer Drug Action and Drug Resistance — From Biology to the Clinic
June 20-23; Florence, Italy
Co-chairpersons: Richard M. Marais, PhD, Pasi A. Jänne, MD, PhD, and Riccardo Dolcetti, MD

Workshop: Methods in Clinical Cancer Research (Europe)
June 20-26; Flims, Switzerland
Co-directors: Stefan Sleijfer, MD, PhD (ECCO), Stephen M. Hahn, MD (AACR), Corneel Coens, MSc (EORTC), and Christian Dittrich, MD (ESMO)

Workshop: Molecular Biology in Clinical Oncology
July 19-26; Snowmass, Colorado
Director: Levi A. Garraway, MD, PhD
Co-directors: Charles L. Sawyers, MD, FAACR, Mark W. Geraci, MD, and Jean Y. Tang, MD, PhD

Workshop: ASCO/AACR Methods in Clinical Cancer Research
July 25-31; Vail, Colorado
Co-directors: S. Gail Eckhardt, MD, Neal J. Meropol, MD, and Yu Shyr, PhD

Workshop: Integrative Molecular Epidemiology
August 10-14; Boston, Massachusetts
Director: Thomas A. Sellers, PhD, MPH
Co-directors: Ellen L. Goode, PhD, and Peter Kraft, PhD

Workshop: Croucher Summer Course in Cancer Biology
August 10-14; Hong Kong
Co-directors: Irene O. L. Ng, MD, PhD, Tak W. Mak, PhD, FAACR, Wendy Hsiao, PhD

CRI-CIMT-EATI-AACR: The Inaugural International Cancer Immunotherapy Conference — Translating Science into Survival
September 16-19; New York, New York
Scientific Planning Committee: James P. Allison, PhD, FAACR, Cedrik M. Britten, MD, Glenn Dranoff, MD, Alexander M.M. Eggermont, MD, PhD, Carl G. Figdor, PhD, Wolf Hervé Fridman, MD, PhD, Philip D. Greenberg, MD, Axel Hoos, MD, PhD, Elizabeth M. Jaffee, MD, Peter W.M. Johnson, MD, Guido Kroemer, MD, PhD, Nils Lonberg, PhD, Cornelis J.M. Melief, PhD, Ellen Puré, PhD, and Robert D. Schreiber, PhD

The AACR collaborated with the Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), and the European Academy of Tumor Immunology (EATI) to launch this groundbreaking conference. More than 1,400 attendees gathered in New York for a sold-out event that brought together leading experts in immunotherapy to discuss the latest developments in the field. Interest in the conference was so high that the collaborating organizations are working to make it an annual event.

Chromatin and Epigenetics in Cancer
September 24-27; Atlanta, Georgia
Co-chairpersons: Peter A. Jones, DSc, PhD, FAACR, Sharon Y.R. Dent, PhD, and Charles M. Roberts, MD, PhD

Advances in Breast Cancer Research
October 17-20; Bellevue, Washington
Co-chairpersons: Matthew J. Ellis, MD, PhD, Charles M. Perou, PhD, and Jane E. Visvader, PhD

Advances in Ovarian Cancer Research
October 17-20; Orlando, Florida
Co-chairpersons: Kathy R. Cho, MD, Benjamin G. Neel, MD, PhD, and Douglas A. Levine, MD

Frontiers in Basic Cancer Research
October 23-26; Philadelphia, Pennsylvania
Chairperson: M. Celeste Simon
Co-chairpersons: James P. Allison, PhD, FAACR, John E. Dick, PhD, Victor E. Velculescu, MD, PhD, and Nathanael S. Gray, PhD

The chairpersons for the latest edition of this biennial conference convened three lectures around the theme "Converging Topics and Emerging Research." These lectures identified the areas of greatest activity in basic research in the past year — "Immunology, Tumor Microenvironment, and Inflammation"; "Cell of Origin, Stem Cells, and Genetics"; and "Genetics and New Technologies in Cancer Research" — and illustrated how collaboration across these disciplines can power progress against cancer.

Basic Science of Sarcomas
November 3-4; Salt Lake City, Utah
[Complementary program to the Connective Tissue Oncology Society Annual Meeting]
Co-chairpersons: Robert G. Maki, MD, PhD, Lee J. Helman, MD, Brian A. Van Tine, MD, PhD, Jonathan A. Fletcher, MD, and Angelo Paolo Dei Tos, MD

AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics
November 5-9; Boston, Massachusetts
Scientific Committee Co-chairpersons: Levi A. Garraway, MD, PhD, Lee J. Helman, MD, and Jean-Charles Soria, MD, PhD

Held biennially in the United States, this conference developed from the original EORTC-NCI meetings on drug discovery and development which began in 1988. The AACR joined the partnership in 1999 in response to the need for more frequent meetings to keep pace with the rapid advancement of molecular biology and genetics, and the consequent emergence of many new targets for cancer therapeutics. In 2015, the U.S. edition offered attendees the opportunity to submit late-breaking abstracts for the first time. A total of 86 late-breaking abstracts were received for consideration as proffered presentations.

Workshop: Translational Cancer Research for Basic Scientists
November 8-13; Boston, Massachusetts
Co-chairpersons: Tom Curran, PhD, FAACR, George D. Demetri, MD, and Pasi A. Jänne, MD, PhD

Advances in Pediatric Cancer Research: From Mechanisms and Models to Treatment and Survivorship
November 9-12; Fort Lauderdale, Florida
Co-chairpersons: Scott A. Armstrong, MD, PhD, Charles G. Mullighan, MBBS, MD, Kevin M. Shannon, MD, and Kimberly Stegmaier, MD

New Horizons in Cancer Research Conference
November 12-15; Shanghai, China
Co-chairpersons: Lewis C. Cantley, PhD, FAACR, and Carlos L. Arteaga, MD, FAACR

Following its successful launch in 2014, the second edition of this annual conference brought the most exciting discoveries from the AACR Annual Meeting 2015 to a receptive audience in China. The program was enhanced with presentations from outstanding international speakers and local experts. The centerpiece of the AACR's international outreach efforts, the New Horizons conference has created a foundation for global collaborations.

EIGHTH ANNUAL AACR CONFERENCE ON THE SCIENCE OF CANCER HEALTH DISPARITIES IN RACIAL/ETHNIC MINORITIES AND THE MEDICALLY UNDERSERVED
November 13-16; Atlanta, Georgia
Co-chairpersons: John M. Carethers, MD, Marcia R. Cruz-Correa, MD, PhD, Mary Jackson Scroggins, MA, Edith A. Perez, MD, Beti Thompson, PhD, and Cheryl L. Willman, MD

Tracing its origins to a 2006 think tank sponsored by the AACR and the NCI Center to Reduce Cancer Health Disparities, this conference is the only one to address the full scientific spectrum of disparities, including basic science, clinical research, population science, behavioral research, and cancer survivorship. The 2015 conference brought together physicians, scientists, health professionals, and health care leaders working in a variety of fields to foster interdisciplinary collaborations.

The keynote address for the conference was delivered by Douglas R. Lowy, MD, FAACR, Acting Director of the National Cancer Institute. Dr. Lowy, who has made reducing cancer health disparities a primary focus of the NCI, discussed “Understanding and overcoming cancer disparities in the U.S. and abroad.”

The 11th Annual Personalized Medicine Conference
November 18-19; Boston, Massachusetts
Co-chairpersons: Raju Kucherlapati, PhD, and Scott Weiss, MD, MS

Developmental Biology and Cancer
November 30-December 3; Boston, Massachusetts
Co-chairpersons: Hans Clevers, MD, PhD, FAACR, Stuart H. Orkin, MD, PhD, and Suzanne J. Baker, PhD

Tumor Metastasis
November 30-December 3; Austin, Texas
Co-chairpersons: Bruce R. Zetter, PhD, Melody A. Swartz, PhD, and Jeffrey W. Pollard, PhD

CSHA-AACR Joint Conference: Big Data, Computation, and Systems Biology in Cancer
December 2-5; Suzhou, China
Organizers: Andrea Califano, PhD, William C. Hahn, MD, PhD, Satoru Miyano, PhD, and Xuegong Zhang, PhD

Noncoding RNAs and Cancer
December 4-7; Boston, Massachusetts
Co-chairpersons: Joshua Mendell, MD, PhD, Jeannie T. Lee, PhD, and Howard Y. Chang, MD, PhD

CTRC-AACR San Antonio Breast Cancer Symposium
December 8-12; San Antonio, Texas
Co-directors: Carlos L. Arteaga, MD, FAACR, Virginia G. Kaklamani, MD, C. Kent Osborne, MD

The 38th annual San Antonio Breast Cancer Symposium also marked the ninth year of the AACR's collaboration with the Cancer Therapy & Research Center at UT Health Science Center San Antonio and Baylor College of Medicine. The 2015 program presented essential cutting-edge science combined with engrossing discussion for basic, translational, and clinical cancer research professionals.